×
  • Select the area you would like to search.
  • ACTIVE INVESTIGATIONS Search for current projects using the investigator's name, institution, or keywords.
  • EXPERTS KNOWLEDGE BASE Enter keywords to search a list of questions and answers received and processed by the ADNI team.
  • ADNI PDFS Search any ADNI publication pdf by author, keyword, or PMID. Use an asterisk only to view all pdfs.
Filter results by:

1739 Total Publications

Heart-type fatty acid binding protein and vascular endothelial growth factor: cerebrospinal fluid biomarker candidates for Alzheimer’s disease.
Guo, L.-H., Alexopoulos, P., & Perneczky, R.
2013; Journal European Archives of Psychiatry and Clinical Neuroscience; vol. 263; no. 7; pp. 553-60; doi:10.1007/s00406-013-0405-4
Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET.
Shokouhi, S., Claassen, D., Kang, H., Ding, Z., Rogers, B., Mishra, A., & Riddle, W. R.
2013; Journal Journal of Nuclear Medicine; vol. 54; no. 9; pp. 1564-9; doi:10.2967/jnumed.112.116137
Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease.
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A.
2013; Journal Nature; vol. 500; no. 7460; pp. 45-50; doi:10.1038/nature12415
Relationship between imaging biomarkers, age, progression and symptom severity in Alzheimer’s disease.
Dukart, J., Mueller, K., Villringer, A., Kherif, F., Draganski, B., Frackowiak, R., & Schroeter, M. L.
2013; Journal Neuroimage: Clinical; vol. 3; pp. 84-94; doi:10.1016/j.nicl.2013.07.005
Effects of baseline CSF alpha-synuclein on regional brain atrophy rates in healthy elders, mild cognitive impairment and Alzheimer’s disease.
Mattsson, N., Insel, P., Tosun, D., Zhang, J., Jack Jr., C. R., Galasko, D., … Weiner, M.
2013; Journal PloS One; vol. 8; no. 12; pp. e85443; doi:10.1371/journal.pone.0085443
STEPS: Similarity and Truth Estimation for Propagated Segmentations and its application to hippocampal segmentation and brain parcelation.
Jorge Cardoso, M., Leung, K., Modat, M., Keihaninejad, S., Cash, D., Barnes, J., … Ourselin, S.
2013; Journal Medical Image Analysis; vol. 17; no. 6; pp. 671-84; doi:10.1016/j.media.2013.02.006
Integrative genomics identifies APOE ε4 effectors in Alzheimer’s disease.
Rhinn, H., Fujita, R., Qiang, L., Cheng, R., Lee, J. H., & Abeliovich, A.
2013; Journal Nature; vol. 500; no. 7460; pp. 45-50; doi:10.1038/nature12415
Locally linear embedding (LLE) for MRI based Alzheimer’s disease classification.
Liu, X., Tosun, D., Weiner, M. W., & Schuff, N.
2013; Journal Neuroimage; vol. 83; pp. 148-57; doi:10.1016/j.neuroimage.2013.06.033
Predicting brain activity using a Bayesian spatial model.
Derado, G., Bowman, F. D., & Zhang, L.
2013; Journal Statistical Methods in Medical Research; vol. 22; no. 4; pp. 382-97; doi:10.1177/0962280212448972
Variance in Brain Volume with Advancing Age: Implications for Defining the Limits of Normality
David Alexander Dickie, Dominic E. Job, David Rodriguez Gonzalez, Susan D. Shenkin, Trevor S. Ahearn, Alison D. Murray, and Joanna M. Wardlaw.
2013; Journal PLoS One; vol. 8; no. 12; pp. e84093;